TransMedics Group, Inc.
NASDAQ:TMDX
Overview | Financials
Company Name | TransMedics Group, Inc. |
Symbol | TMDX |
Currency | USD |
Price | 61.02 |
Market Cap | 2,047,922,730 |
Dividend Yield | 0% |
52-week-range | 59.722 - 177.37 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Waleed H. Hassanein M.D. |
Website | https://www.transmedics.com |
An error occurred while fetching data.
About TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD